Author: Persist AI Formulations

Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage “Micromill” Formulation Platform, Enabling Drug Development Decision With Milligrams of API

June 3, 2026
The Solubility Company and Persist AI Unveil Strategic Partnership to Enable Microgram-Level Formulation Development and Bridge the Data Gap in AI-Driven Drug Formulation

May 13, 2026

Persist AI Teams up with Microsize and Micromacinazione (Micmac) to Launch First-of-Its-Kind Early-Stage “Micromill” Formulation Platform, Enabling Drug Development Decision With Milligrams of API